These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23634995)
21. Mutation of CEBPA in familial acute myeloid leukemia. Smith ML; Cavenagh JD; Lister TA; Fitzgibbon J N Engl J Med; 2004 Dec; 351(23):2403-7. PubMed ID: 15575056 [TBL] [Abstract][Full Text] [Related]
22. Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience. Hussaini MO; Mirza AS; Komrokji R; Lancet J; Padron E; Song J Cancer Genomics Proteomics; 2018; 15(2):121-126. PubMed ID: 29496691 [TBL] [Abstract][Full Text] [Related]
23. [Detection of the IDH1 gene mutation in acute myeloid leukemia by PCR-high resolution melting analysis]. Lin J; Qian J; Yao DM Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):484-6. PubMed ID: 22213873 [No Abstract] [Full Text] [Related]
24. Nucleophosmin gene mutation in acute myeloid leukemia patients. Khorshied MM; Said WA; Shaaban HA Saudi Med J; 2010 May; 31(5):582-4. PubMed ID: 20464055 [No Abstract] [Full Text] [Related]
31. Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD. Hou HA; Chou WC; Lin LI; Chen CY; Tang JL; Tseng MH; Huang CF; Chiou RJ; Lee FY; Liu MC; Tien HF Leukemia; 2008 May; 22(5):1075-8. PubMed ID: 17972951 [No Abstract] [Full Text] [Related]
32. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation. Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108 [No Abstract] [Full Text] [Related]
33. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. Bullinger L; Döhner K; Döhner H J Clin Oncol; 2017 Mar; 35(9):934-946. PubMed ID: 28297624 [TBL] [Abstract][Full Text] [Related]
35. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. Georgiou G; Efthymiou A; Vardounioti I; Boutsikas G; Angelopoulou MK; Vassilakopoulos TP; Kyrtsonis MC; Plata E; Tofas P; Bitsani A; Bartzi V; Pessach I; Dimou M; Panayiotidis P Leukemia; 2012 Apr; 26(4):824-6. PubMed ID: 21986839 [No Abstract] [Full Text] [Related]
36. Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience. Sayar H; Bashardoust P; Cripe L; Chakraborty S; Bai S Am J Hematol; 2017 Feb; 92(2):E17-E18. PubMed ID: 27813149 [No Abstract] [Full Text] [Related]
37. JAK2V617F mutations as cooperative genetic lesions in t(8;21)-positive acute myeloid leukemia. Döhner K; Du J; Corbacioglu A; Scholl C; Schlenk RF; Döhner H Haematologica; 2006 Nov; 91(11):1569-70. PubMed ID: 17043013 [TBL] [Abstract][Full Text] [Related]
38. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia. Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family. Cazzaniga G; Lo Nigro L; Cifola I; Milone G; Schnittger S; Haferlach T; Mirabile E; Costantino F; Martelli MP; Mastrodicasa E; Di Raimondo F; Aversa F; Biondi A; Falini B Leukemia; 2009 Jan; 23(1):199-203. PubMed ID: 18596743 [No Abstract] [Full Text] [Related]
40. Exclusion of ABCB8 and ABCB10 as cancer candidate genes in acute myeloid leukemia. Tang L; Bergevoet SM; Franssen LE; de Witte T; Jansen JH; Raymakers RA; van der Reijden BA Leukemia; 2009 May; 23(5):1000-2. PubMed ID: 19151771 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]